Eicosanoids are derived from 20-carbon polyunsaturated fatty acids and play important roles in human physiology. They include prostaglandins, thromboxanes, and leukotrienes, which are produced via the cyclooxygenase, lipoxygenase, and epoxygenase pathways. Specific eicosanoids have roles in inflammation and pain, vascular function, bronchial contraction, gastrointestinal function, and uterine contraction. Prostaglandins and leukotrienes are involved in processes like platelet aggregation, vasodilation, smooth muscle contraction, and inflammation. They are also used therapeutically to induce labor or abortion and maintain ductus arteriosus patency in newborns.
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Eicosanoids and It’s role in Human Physiology
1. Eicosanoids and its
role in Human
Physiology
Dr. Anupam Mittal
MBBS, MD
King George’s Medical University, Lucknow
2. What is Eicosanoids?
• Greek: eikosi / “eicosa” → twenty
• Derived from 20 C Poly - unsaturated Fatty Acids
• Produced by almost all mammalian cells
• Not synthesised in advance / stored : synthesised as and when needed
3. Primary Precursor of Eicosanoid
Arachidonic acid (w6)
A 20-carbon chain fatty acid that include cyclic ring structure
6. Moore, G.Y.; Pidgeon, G.P. Cross-Talk between Cancer Cells and the Tumour Microenvironment: The
Role of the 5-Lipoxygenase Pathway. Int. J. Mol. Sci. 2017, 18, 236.
7. Cyclooxygenase Pathway
PGD2 :
• Produced by Mast Cells
• Effect on inflammation in the asthmatic airways through
increased inflammatory cell chemotaxis and cytokine production
8. Domingo, C., Palomares, O., Sandham, D.A. et al. The prostaglandin D2 receptor 2 pathway in asthma: a
key player in airway inflammation. Respir Res 19, 189 (2018). https://doi.org/10.1186/s12931-018-0893-x
9. Cyclooxygenase Pathway
PGI2 / Prostacyclin :
• Produced primarily by endothelium of vessels
• Vasodilation
• Inhibits platelet aggregation
18. 5 – Lipoxygenase Pathway
LTA4 :
• Produced in leukocytes, platelets, mast cells, and heart and lung
vascular tissues
• An unstable substance whose main function is to serve as a substrate
for the biosynthesis of other LTs.
19. 5 – Lipoxygenase Pathway
LTB4 :
• Increased chemotaxis of polymorphonuclear leukocytes
• Release of lysosomal enzymes
• Adhesion of white blood cells
20. 5 – Lipoxygenase Pathway
Peptido Leukotrienes : LTC4 —> LTD4 —> LTE4
• Contraction of smooth muscle • Bronchoconstriction
• Vasoconstriction • Increased vascular permeability
• Cysteinyl LTs makeup slow reacting substance of anaphylaxis
• Involved in the pathophysiology of Asthma
21. Tsai M-J, Chang W-A, Chuang C-H, Wu K-L, Cheng C-H, Sheu C-C, Hsu Y-L, Hung J-Y. Cysteinyl Leukotriene
Pathway and Cancer. International Journal of Molecular Sciences. 2022; 23(1):120.
https://doi.org/10.3390/ijms23010120
29. Tsai M-J, Chang W-A, Chuang C-H, Wu K-L, Cheng C-H, Sheu C-C, Hsu Y-L, Hung J-Y. Cysteinyl Leukotriene
Pathway and Cancer. International Journal of Molecular Sciences. 2022; 23(1):120.
https://doi.org/10.3390/ijms23010120
30.
31. Gastrointestinal Tract
PGE2 and PGI2 : Inhibit Acid and Pepsinogen
(Stomach secretion)
Prostaglandins : Stimulates synthesis of protective mucus
in
( PGE2 and PGF2a ) both stomach and the intestine
32. Gastrointestinal Tract
PGE2 and PGF2a : Increase the rate of longitudinal contraction in the
gut
Leukotrienes : Potent stimulators of gastrointestinal smooth
muscle
36. Management of Ductus Arteriosus
Maintenance:
Produced by PGE1 infusion
• Maintain patency, which may be desirable before surgery
Editor's Notes
Phospholipids are polar, ionic compounds composed of an alcohol attached by a phosphodiester bridge to either diacylglycerol (producing phosphatidylcholine or phosphatidyl ethanolamine) or to sphingosine.
C20H32O2, 20:4 (ω-6)
Present as a component of the phospholipids of cell membrane
Epoprostenol / iLoprost: IV Admin, PGI2 analog Potent pulmonary vasodilator used for pulmonary arterial hypertension.
Acts PGI2 on Endothelial cells --> reduction in pulmonary artery resistance
PGI2 : Normally inhibits Gastric Secretion
Inhibit Platelet aggregation: Binds to Platelet, act on membrane receptor, synthesis on cAMP, increased leve cAMP associated with decreased level of calcium, low level Ca+ prevent platelet activation and prevent release of platelet aggregation agent.
Inhibit Platelet aggregation: Binds to Platelet, act on membrane receptor, synthesis on cAMP, increased leve cAMP associated with decreased level of calcium, low level Ca+ prevent platelet activation and prevent release of platelet aggregation agent.
Produced primarily by platelets • Promotes platelet aggregation • Vasoconstriction • Mobilizes intracellular calcium • Contraction of smooth muscle
Low doses of Aspirin ( 75-162mg - commonly 81mg) - 3hr
High dose : 15 hr
Stimuli – Inhibited PGI2, Thrombin, Collagen, Growth Factor, Bradykinin, Angiotensin II, Arginine
Stimulate production of TXA2 and release it from platelet with Calcium, ADP, PAF and Other mediators and acts
Platelet aggregation
Vasoconstriction
Release of IL17 – Neutrophil activation and mobilization
Stimuli – Inhibited PGI2, Thrombin, Collagen, Growth Factor, Bradykinin, Angiotensin II, Arginine
Stimulate production of TXA2 and release it from platelet with Calcium, ADP, PAF and Other mediators and acts
Platelet aggregation
Vasoconstriction
Release of IL17 – Neutrophil activation and mobilization
Stimuli – Inhibited PGI2, Thrombin, Collagen, Growth Factor, Bradykinin, Angiotensin II, Arginine
Stimulate production of TXA2 and release it from platelet with Calcium ADP, Other mediators and acts
Platelet aggregation
Vasoconstriction
Release of IL17 – Neutrophil activation and mobilization
Misoprostol: a methylated derivative of PGE1, use in patients taking high doses of NSAIDs to reduce gastric ulceration.
Interacts with parietal cell within stomach, reduced gastric acid secretion. And Stimulating mucus and bicarbonate production.
Contraindicated during pregnancy, can induce abortion by increasing uterine contraction by prostaglandin receptors in the uterus.
Lubiprostone : PGE1 analoge to relieve opioid induced constipation
SE: Diarrhoea, Vomiting
PGF 2a : ( Bimatoprost, Latanoprost, Tafluprost ) : analogs for open angle glaucoma as Ophthalmic solution once a day
By prostaglandin receptor --> increase uveoscleral outflow and reduce intraocular pressure.
Also increases eyelash prominence, length and darkness
Sometimes iris color change (increase brown pigmentation)
Treatment for Eyelash Hypotrichosis
TXA2 : initial modification involving breakdown of bond between C9-C11
PGs are designated in series as - A, B, C ....I etc. depending on ring structure and substitution
LTB4 could trigger aggregation and adherence of leukocytes to the endothelium.
Each series is named 1,2,3 indicating no. of double bonds
PGE2 contributes to peripheral sensitization by potentiation of TRPV1 (transient receptor potential subtype V1) and T-type calcium channel activity, activation of TTX-R Na+ (tetrodotoxin-resistant sodium channels) and purinergic P2X3 receptors channels,
inhibition of voltage-gated potassium currents, particularly through the EP1 and EP4 receptors.
PGE2 also exerts indirect effects for example by enhancing the sensitivity of sensory neurons to bradykinin.
(B) Inflammation upregulates COX-2 and mPGES-1 expression in the spinal cord and increases PGE2 production. PGE2 , mainly acting on EP2 receptor, contributes to central sensitization through both
presynaptic and post-synaptic mechanisms.
At the presynaptic level, PGE2 facilitates the spinal release of the excitatory neurotransmitter glutamate (Glu), substance-P (SP), or calcitonin gene-related peptide (CGRP), resulting in enhanced nociceptive processing. At the post-synaptic level, PGE2 directly activates dorsal horn neurons, enhances AMPAR and NMDAR activity, or blocks inhibitory glycinergic neurotransmission (TRPV1, transient receptor potential subtype V1; TTX-R, tetrodotoxin-resistant sodium channels;
NMDAR, N-methyl-d-aspartic acid receptor; AMPAR, quisqualate receptor; NK1R, neurokinin-1 receptor; CGRPR, CGRP receptor).
from journals.physiology.org/journal/physiologyonline (183.082.161.090) on November 18, 2023.
PGE2 and PGI2 : Vasodilators in most vascular beds
Thromboxane : Vasoconstrictor, Platelet aggregation
Misoprostol: a methylated derivative of PGE1, use in patients taking high doses of NSAIDs to reduce gastric ulceration.
PGFs : Smooth muscle contraction via gq—ip3—ca+
PGEs : Smooth muscle relaxation via cAMP
Montelukast, Zafirlukast : Leukotrien antagonist (CysLT2R)
Misoprostol: a methylated derivative of PGE1, use in patients taking high doses of NSAIDs to reduce gastric ulceration.
Interacts with parietal cell within stomach, reduced gastric acid secretion. And Stimulating mucus and bicarbonate production.
Contraindicated during pregnancy, can induce abortion by increasing uterine contraction by prostaglandin receptors in the uterus.
Lubiprostone : PGE1 analoge to relieve opioid induced constipation
PGF 2a : ( Bimatoprost, Latanoprost, Tafluprost ) : analogs for open angle glaucoma as Ophthalmic solution once a day
By prostaglandin receptor --> increase uveoscleral outflow and reduce intraocular pressure.
Also increases eyelash prominence, length and darkness
Sometimes iris color change (increase brown pigmentation)
Treatment for Eyelash Hypotrichosis
In third trimester avoid NSAID : risk of premature closing of Ductus arteriosus
Connects the main pulmonary artery and the aorta in fetal circulation and closes spontaneously within days after birth in normal infant
Alprostadil . Prostin VR
Closure:
Indomethacin is given at birth to close the PDA (0.2mg/kg IV)
PGE2 is produced in both the placenta and the DA in fetal circulation. It maintains DA patency through various PGE receptors. Activation of PGE2 receptors increases intracellular cyclic AMP (cAMP) via adenylyl cyclases and the increased cAMP level inhibits myosin light chain kinase, subsequently dilating DA.
Alprostadil (PGE1) : Injected directly into the corpus cavernosum or administered as a transurethral suppository to cause vasodilation and enhance tumescence.
Closure:
Indomethacin is given at birth to close the PDA
Alprostadil (PGE1) : Injected directly into the corpus cavernosum or administered as a transurethral suppository to cause vasodilation and enhance tumescence.